Cigna Group (NYSE:CI) Coverage Initiated at The Goldman Sachs Group

Research analysts at The Goldman Sachs Group started coverage on shares of Cigna Group (NYSE:CI) in a report issued on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $370.00 price target on the health services provider’s stock. The Goldman Sachs Group’s price target would indicate a potential upside of 25.51% from the company’s current price.

A number of other equities research analysts have also recently commented on CI. TD Cowen upgraded Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Truist Financial set a $375.00 target price on Cigna Group in a research report on Tuesday, September 2nd. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a report on Friday, October 3rd. Robert W. Baird set a $372.00 price objective on Cigna Group in a report on Thursday, August 14th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $369.89.

Cigna Group Price Performance

Shares of CI opened at $294.79 on Tuesday. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.88. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a market capitalization of $78.69 billion, a P/E ratio of 16.09, a P/E/G ratio of 0.89 and a beta of 0.45. The business’s 50-day moving average is $296.36 and its two-hundred day moving average is $308.77.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. During the same period last year, the firm earned $6.72 EPS. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Insider Activity at Cigna Group

In other news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by insiders.

Institutional Trading of Cigna Group

Several institutional investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD raised its position in shares of Cigna Group by 10.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after buying an additional 1,094,327 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in Cigna Group by 1.1% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock valued at $3,893,727,000 after purchasing an additional 123,479 shares during the last quarter. Dodge & Cox increased its holdings in Cigna Group by 0.7% in the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock valued at $2,958,893,000 after purchasing an additional 60,877 shares during the last quarter. GQG Partners LLC increased its holdings in Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the last quarter. Finally, Valeo Financial Advisors LLC increased its holdings in Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.